Heterozygous familial hypercholesterolemia: We must develop a new clinical paradigm.

Congenit Heart Dis

Associate Chief of Cardiology Texas Children's Hospital Professor of Pediatrics, Baylor College of Medicine 6621 Fannin Street MC, 19345-C, Houston, Texas 77030, USA.

Published: September 2016

Download full-text PDF

Source
http://dx.doi.org/10.1111/chd.12411DOI Listing

Publication Analysis

Top Keywords

heterozygous familial
4
familial hypercholesterolemia
4
hypercholesterolemia develop
4
develop clinical
4
clinical paradigm
4
heterozygous
1
hypercholesterolemia
1
develop
1
clinical
1
paradigm
1

Similar Publications

Elucidating the genetic contributions to Parkinson's disease (PD) etiology across diverse ancestries is a critical priority for the development of targeted therapies in a global context. We conducted the largest sequencing characterization of potentially disease-causing, protein-altering and splicing mutations in 710 cases and 11,827 controls from genetically predicted African or African admixed ancestries. We explored copy number variants (CNVs) and runs of homozygosity (ROHs) in prioritized early onset and familial cases.

View Article and Find Full Text PDF

Inherited retinal diseases (IRDs) constitute a heterogeneous group of clinically and genetically diverse conditions, standing as a primary cause of visual impairment among individuals aged 15-45, with an estimated incidence of 1:2000. Our study aimed to comprehensively evaluate the genetic variants underlying IRDs in the Turkish population. This study included 50 unrelated Turkish IRD patients and their families.

View Article and Find Full Text PDF

This study investigated two cases. Case 1 involves a 53-year-old man who suffered from sleep apnea syndrome at age 48. Moreover, he was involved in a rear-end collision while driving and was admitted to the hospital at age.

View Article and Find Full Text PDF

Introduction: POT1 tumor predisposition (POT1-TPD) is an autosomal dominant disorder characterized by increased lifetime malignancy risk. Melanoma, angiosarcoma, and chronic lymphocytic leukemia are the most frequently reported malignancies [1]. Protection of telomeres protein 1 (POT1) is part of the shelterin protein complex to maintain/protect telomeres [2].

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!